Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
Get Insiders for : 
Hologic Inc (HOLX)  
$75.02 0.07 (0.09%) as of 4:30 Fri 5/17


Download
   
Exchange: Nasdaq National Market
Security Type: Common
Shares Out: 258,990,000
Market Cap: 19.43(B)
Last Volume: 1,451,370 Avg Vol: 1,905,632
52 Week Range: $65.11 - $82.04
Level I Sector: Health Care
Level II Sector: Health Services
Level III Sector: Medical Appliances & Equipment

Member Indexes:

    S&P COMPOSITE 1500     NASDAQ COMPOSITE
    S&P SMALLCAP 600     NASDAQ NNM COMPOSITE

Rankings:

     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  317
Guru Rank Value     : 4
Guru Occurances    : 2

 

            6 Months   1 Year   2 Year  
 
Company Profile   Hologic develops, manufactures and supplies diagnostics products, medical imaging systems, and surgical products focused on women's health and well-being. Co.'s segments are: Diagnostics, which provides diagnostic products used in screening and diagnosis of human diseases; Breast Health, which provides solutions for breast cancer care in the areas of radiology, breast surgery, pathology and treatment; GYN Surgical, which include NovaSure endometrial ablation system, MyoSure hysteroscopic tissue removal system, Fluent fluid management system, as well as Acessa ProVu laparoscopic radiofrequency ablation system; and Skeletal Health, which include the Horizon DXA, a dual energy x-ray system.


 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 26,945 123,113 123,113 368,767
Total Sell Value $2,043,551 $8,902,469 $8,902,469 $27,563,219
Total People Sold 3 6 6 10
Total Sell Transactions 3 8 8 16
End Date 2024-02-18 2023-11-17 2023-05-19 2022-05-19

   
Records found: 1696
  Page 11 of 68  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

 
3m +/-  
Form
   Oberton Karleen Marie Chief Financial Officer   •       •      –    2020-11-02 4 A $0.00 $0 D/D 16,941 51,358     -
   Verstreken Jan Group President, International   •       •      –    2020-11-02 4 A $0.00 $0 D/D 16,797 42,778     -
   Thornal Kevin R Div. President, Diagnostics   •       •      –    2020-11-02 4 A $0.00 $0 D/D 17,750 34,776     -
   Bebo Allison P SVP, Human Resources   •       •      –    2020-11-02 4 A $0.00 $0 D/D 16,797 45,186     -
   Griffin John M. General Counsel   •       •      –    2020-11-02 4 A $0.00 $0 D/D 34,716 130,023     -
   Verstreken Jan Group President, International   •       –      –    2020-10-26 3 IO $0.00 $0 D/D 0 25,981 3%     
   Oberton Karleen Marie Chief Financial Officer   •       •      –    2020-09-22 4 OE $26.21 $143,133 D/D 5,461 34,417     -
   Oberton Karleen Marie Chief Financial Officer   •       •      –    2020-09-21 4 AS $62.50 $937,500 D/D (15,000) 28,956 26%     
   Oberton Karleen Marie Chief Financial Officer   •       •      –    2020-09-21 4 OE $26.21 $393,150 D/D 15,000 43,956     -
   Daugherty Sean S. Group President, BSH & Surg.Of   •       –      –    2020-08-31 3 IO $0.00 $0 D/D 0 14,507 30%     
   Cohn Benjamin Jordan Principal Accounting Officer   •       •      –    2020-08-03 4 S $71.22 $350,810 D/D (4,924) 16,713 -4%     
   Cohn Benjamin Jordan Principal Accounting Officer   •       •      –    2020-08-03 4 OE $23.82 $71,127 D/D 2,986 19,699     -
   Valenti Peter J. Iii Division Pres., Breast Health   •       •      –    2020-06-30 4 AS $54.07 $567,357 D/D (10,493) 59,991 17%     
   Valenti Peter J. Iii Division Pres., Breast Health   •       •      –    2020-06-30 4 OE $26.21 $275,022 D/D 10,493 70,484     -
   Crawford Sally Director   •       •      –    2020-05-22 4 S $51.99 $1,661,081 D/D (31,950) 126,847 -29%     
   Valenti Peter J. Iii Division Pres., Breast Health   •       •      –    2020-05-22 4 S $51.82 $543,779 D/D (10,493) 59,991 -29%     
   Valenti Peter J. Iii Division Pres., Breast Health   •       •      –    2020-05-22 4 OE $26.21 $275,022 D/D 10,493 70,484     -
   Thornal Kevin R Div. President, Diagnostics   •       •      –    2020-05-15 4 S $51.51 $715,426 D/D (13,888) 17,026 -25%     
   Thornal Kevin R Div. President, Diagnostics   •       •      –    2020-05-15 4 OE $26.01 $361,227 D/D 13,888 30,914     -
   Macmillan Stephen P Chairman, President and CEO   •       •      –    2020-05-13 4 S $50.97 $9,735,257 D/D (190,996) 1,722,442 -24%     
   Macmillan Stephen P Chairman, President and CEO   •       •      –    2020-05-13 4 OE $22.29 $4,814,551 D/D 215,996 1,913,438     -
   Garrett Scott T Director   •       •      –    2020-05-01 4 OE $20.34 $492,309 D/D 24,204 51,385     -
   Griffin John M. General Counsel   •       •      –    2020-04-28 4 AS $50.00 $245,300 D/D (4,906) 95,307 16%     
   Griffin John M. General Counsel   •       •      –    2020-04-28 4 OE $32.38 $158,856 D/D 4,906 97,440     -
   Crawford Sally Director   •       •      –    2020-03-09 4 AS $43.57 $491,317 D/D (11,146) 158,797 31%     

  1696 Records found
  Previous  10  11  12  13  14  15  16  17  18  19  Next   
  Page 11 of 68
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed